Call Start: 16:30 January 1, 0000 5:52 PM ET
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Q3 2023 Earnings Conference Call
November 08, 2023, 16:30 ET
Company Participants
Andrea Flynn - VP & Head, IR
Bruce Cozadd - Co-Founder, Chairman & CEO
Renee Gala - President & COO
Robert Iannone - EVP & Global Head, Research & Development
Kim Sablich - EVP & GM, US
Conference Call Participants
Jessica Fye - JPMorgan Chase & Co.
Jason Gerberry - Bank of America Merrill Lynch
Ami Fadia - Needham & Company
Jeremy Jacoby - Truist Securities
Amy Li - Jefferies
Elaine Kim - Cantor Fitzgerald
Troy Langford - TD Cowen
Balaji Prasad - Barclays Bank
Jeff Hung - Morgan Stanley
Gary Nachman - Raymond James & Associates
Marc Goodman - Leerink Partners
Gregory Renza - RBC Capital Markets
Mohit Bansal - Wells Fargo Securities
David Amsellem - Piper Sandler & Co.
Operator
Good afternoon. My name is Krista, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions].
I would now like to turn the conference over to Andrea Flynn, Vice President, Head of Investor Relations. You may begin.
Andrea Flynn
Thank you, operator, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported its third quarter 2023 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website.
On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, President and Chief Operating Officer; and Rob Iannone, Executive Vice President, Global Head of R&D; Kim Sablich, Executive Vice President and General Manager, United States, will join the team for Q&A.
On Slide 2, I'd like to remind you that today's webcast includes forward-looking statements, such as those related to our future financial and operating results, growth potential and anticipated development and commercialization milestones and goals, which involve risks and uncertainties that could cause actual events, performance and results to differ materially from those contained in these forward-looking statements.
We encourage you to review the statements contained in today's press release, in our slide deck and in our latest SEC disclosure documents, which identify certain factors that may cause the company's actual events, performance and results to differ materially from those contained in the forward-looking statements made on today's webcast. We undertake no duty or obligation to update our forward-looking statements.